Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Duavive |
| Active Ingredients: | Bazedoxifene acetate 22.56mg equivalent to bazedoxifene 20mg Conjugated estrogens 0.45mg |
| Dosage Form: | Modified release tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Ireland Pharmaceuticals, Newbridge, Ireland |
| Product: | PIQRAY |
| Active Ingredient: | Alpelisib 150mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer: | Novartis Pharma Stein AG, Stein, Switzerland |
| Product: | PIQRAY |
| Component 1: | |
| Active Ingredient: | Alpelisib 50mg |
| Dosage Form: | Film coated tablet |
| Component 2: | |
| Active Ingredient: | Alpelisib 200mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer: | Novartis Pharma Stein AG, Stein, Switzerland |
| Product: | PIQRAY |
| Active Ingredient: | Alpelisib 200mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer: | Novartis Pharma Stein AG, Stein, Switzerland |
Dated this 27th day of May 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).